Ethyl Nipecotate CAS 5006-62-2 Assay ≥99.0% (GC) Mea Kiʻekiʻe

ʻO ka wehewehe pōkole:

Inoa Kemika: Ethyl Nipecotate

CAS: 5006-62-2

ʻAno: ʻAʻole waihoʻoluʻu i ka wai melemele ʻeleʻele

ʻIke: ≥99.0% (GC)

Kūlana Kiʻekiʻe, Hana Kūʻai

E-mail: alvin@ruifuchem.com


Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Hoʻolako me ka maʻemaʻe kiʻekiʻe a me ka maikaʻi paʻa
Inoa Kemika: Ethyl Nipecotate
CAS: 5006-62-2
Kūlana Kiʻekiʻe, Hana Kūʻai

Na Waiwai Kemika:

Inoa Kimia Ethyl Nipecotate
Nā huaʻōlelo like Ethyl 3-Piperidinecarboxylate;Ethyl piperidine-3-carboxylate;3-Piperidinecarboxylic Acid Ethyl Ester
Helu CAS 5006-62-2
Helu CAT RF-PI271
Kūlana Kūʻai Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā tona
ʻĀpana Molekala C8H15NO2
Kaumaha Molecular 157.21
Lae hehee 165.0~167.0 ℃
Lae paila 102-104 ℃ /7 mmHg (māmā)
ʻO ka mānoanoa 1.012 g/mL ma 25 ℃ (māmā)
Hōʻike Hōʻike n20/D 1.460 (māmā)
Hiki i ka wai Miscible
Kūlana Hoʻouna Hoʻouna ʻia ma lalo o ka wela ambient
Brand ʻO Ruifu Chemical

Nā kikoʻī:

'ikamu Nā kikoʻī
Ka nana aku ʻAʻole waihoʻoluʻu i ka wai melemele ʻeleʻele
Wai ≤0.50%
Hoʻokahi haumia ≤0.50%
Huina paumaele ≤1.0%
Metala Kaumaha ≤20ppm
Hoʻāʻo ≥99.0%
Kūlana hoʻāʻo ʻOihana Kūlana
Hoʻohana Nā Kūwaena Lapaʻau

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻO ka'ōmole, Barrel, 25kg / Barrel, aiʻole e like me ka makemake o ka mea kūʻai.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Palekana mai ka malamalama, ka ma'ū a me ka pest infestation.

Pono:

1

FAQ:

Noi:

ʻO Shanghai Ruifu Chemical Co., Ltd. ka mea hana nui a me ka mea hoʻolako o Ethyl Nipecotate (CAS: 5006-62-2) me ke kūlana kiʻekiʻe, hoʻohana nui ʻia i ka synthesis organik, synthesis o nā intermediates pharmaceutical a me Active Pharmaceutical Ingredient (API) synthesis.

Hoʻohana ʻia ʻo Ethyl Nipecotate (CAS: 5006-62-2) i ka synthesis o: α,α′-bis [3- (N, N-diethylcarbamoyl) -piperidino]-p-xylene;2-amino-4-thiazolyl derivative o 3-(iso-propyl-3-piperidinyl)phenol;

Reactant no ka hana ʻana o: Squalene synthase inhibitors;ʻO 4-aminomethyl-7,8-dihydroxycoumarines a me kā lākou lei aliʻi ether derivatives;Spiroimidazolidinone NPC1L1 inhibitors;ʻO nā modulators sensing quorum;Nā mea kū'ē i ka serotonin koho 5-HT6;ʻO Oxazolidinone RNA-binding agents.

E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou